HB2100: Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.

IntroducedHouse

Introduced

In Committee

Passed Chamber

Passed Both

Signed

Plain-Language Summary

This bill allows pharmacists to give certain patients medicine after they've been exposed to HIV. It also protects pharmacists from being sued if something goes wrong.

Who This Affects

Kansans who work in healthcare or have jobs that put them at risk of exposure to HIV, such as emergency responders and medical professionals, will be affected by this bill.

Key Provisions

• Permits pharmacists to initiate HIV post-exposure prophylaxis (PEP) for certain patients • Provides civil liability protections to pharmacists who initiate PEP therapy • Establishes statewide standards governing the use of HIV PEP

AI-generated summary · verify with full bill text

Timeline

Introduced

Sunday, January 26, 2025

Last Action

House Withdrawn from Committee on Health and Human Services; Rereferred to Committee on Insurance

Apr 8, 2026

Plain-Language Summary

Who This Affects

Key Provisions

Timeline

Sponsors

Track This Bill